These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20729952)

  • 41. Clinicopathological relevance of the association between gastrointestinal and sebaceous neoplasms: the Muir-Torre syndrome.
    Paraf F; Sasseville D; Watters AK; Narod S; Ginsburg O; Shibata H; Jothy S
    Hum Pathol; 1995 Apr; 26(4):422-7. PubMed ID: 7705822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Muir-Torre syndrome (MTS): An update and approach to diagnosis and management.
    John AM; Schwartz RA
    J Am Acad Dermatol; 2016 Mar; 74(3):558-66. PubMed ID: 26892655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Well-concealed advanced duodenal carcinoma with Muir-Torre syndrome: a case report and review of literature.
    Sugi T; Shimomura O; Hashimoto S; Takahashi K; Doi M; Miyazaki Y; Enomoto T; Akashi Y; Araki K; Oda T
    Surg Case Rep; 2023 Feb; 9(1):24. PubMed ID: 36781705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
    Abbas O; Mahalingam M
    J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Muir-Torre syndrome-is it really a new syndrome?
    Grzybowski A; Jabłońska S
    Am J Dermatopathol; 2009 Dec; 31(8):799-802. PubMed ID: 19955878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MSH6, Past and Present and Muir-Torre Syndrome-Connecting the Dots.
    Mahalingam M
    Am J Dermatopathol; 2017 Apr; 39(4):239-249. PubMed ID: 28323777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Case report: Muir-Torre syndrome diagnosed from a sebaceoma mimicking an ulcerated breast cancer].
    Demolin G; Romain M; Münschke A; Vandingenen T; Blaude MA; Van Craynest MP
    J Gynecol Obstet Biol Reprod (Paris); 2016 Sep; 45(7):767-74. PubMed ID: 26321614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Muir-Torre syndrome: clinical features and molecular genetic analysis.
    Esche C; Kruse R; Lamberti C; Friedl W; Propping P; Lehmann P; Ruzicka T
    Br J Dermatol; 1997 Jun; 136(6):913-7. PubMed ID: 9217825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple benign adnexal tumours: Anything but benign.
    McCarthy RL; Thomas CL; Isaacs F
    Australas J Dermatol; 2019 Aug; 60(3):234-236. PubMed ID: 30671930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
    Jessup CJ; Redston M; Tilton E; Reimann JD
    Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation.
    Suspiro A; Fidalgo P; Cravo M; Albuquerque C; Ramalho E; Leitão CN; Costa Mira F
    Am J Gastroenterol; 1998 Sep; 93(9):1572-4. PubMed ID: 9732950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The liver: another organ involved in Muir Torre syndrome?
    Morando F; Alaibac M; Romano A; Cavallin M; Piano S; Pizzi M; Mescoli C; Pilati P; Gatta A; Angeli P
    Fam Cancer; 2012 Mar; 11(1):7-12. PubMed ID: 21614588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Muir-Torre syndrome: case report and molecular characterization.
    Rios CA; Villalón R; Muñoz J; Acuña M; Cifuentes L
    Sao Paulo Med J; 2014; 132(1):61-4. PubMed ID: 24474082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Muir-Torre syndrome].
    Yoshikawa R; Utsunomiya J
    Nihon Rinsho; 1995 Nov; 53(11):2803-6. PubMed ID: 8538048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Papillary Renal Cell Carcinoma in Lynch/Muir-Torre Syndrome with Germline Pathogenic Variant in
    Yang Y; Dhar S; Taylor J; Krishnan B
    J Kidney Cancer VHL; 2021; 8(2):8-19. PubMed ID: 33977078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Muir-Torre syndrome.
    Johnson PJ; Heckler F
    Ann Plast Surg; 1998 Jun; 40(6):676-7. PubMed ID: 9641292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.
    Landis MN; Davis CL; Bellus GA; Wolverton SE
    J Am Acad Dermatol; 2011 Nov; 65(5):1054-1058.e1. PubMed ID: 21550136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
    Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
    Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Second hit" in sebaceous tumors from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation.
    Kruse R; Rütten A; Hosseiny-Malayeri HR; Bisceglia M; Friedl W; Propping P; Ruzicka T; Mangold E
    J Invest Dermatol; 2001 Mar; 116(3):463-5. PubMed ID: 11231323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sebaceous neoplasia and Torre-Muir syndrome.
    Lazar AJ; Lyle S; Calonje E
    Curr Diagn Pathol; 2007 Aug; 13(4):301-319. PubMed ID: 18670585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.